Eltrombopag-induced recurrent stroke in idiopathic thrombocytopenic purpura

被引：0
|
作者：
Maeda, Yukinori [1 ]
Yamamoto, Daisuke [1 ]
Tamai, Yotaro [2 ]
机构：
[1] Shonan Kamakura Gen Hosp, Dept Neurol, Kamakura, Kanagawa, Japan
[2] Shonan Kamakura Gen Hosp, Dept Hematol, Kamakura, Kanagawa, Japan
来源：
BMJ CASE REPORTS | 2021年 / 14卷 / 03期
关键词：
haematology (incl blood transfusion); neuroimaging; stroke;
D O I：
10.1136/bcr-2021-241895
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Paradoxical ischaemic stroke in the setting of idiopathic thrombocytopenic purpura
    Phan, T. G.
    Owen, R.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (08) : 643 - 644
  • [32] Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura A NICE Single Technology Appraisal
    Boyers, Dwayne
    Jia, Xueli
    Jenkinson, David
    Mowatt, Graham
    PHARMACOECONOMICS, 2012, 30 (06) : 483 - 495
  • [33] Idiopathic thrombocytopenic purpura induced by PEG interferon
    de Manuel Moreno, J.
    Costero Pastor, B.
    Sandoval Martinez, A.
    Villafruela Cives, M.
    Bejarano Redondo, L.
    del Pozo Prieto, D.
    Beceiro Pedreno, I.
    Borrego Rodriguez, G.
    Poves Martinez, E.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2010, 102 (06) : 400 - 401
  • [34] Idiopathic Thrombocytopenic Purpura Induced by Synthetic Cannabinoid
    Castaneira, Giselle
    Rojas, Kelley
    Galili, Yehuda
    Field, Zachary
    Perez-Perez, Ariel
    Madruga, Mario
    Carlan, Steve J.
    JOURNAL OF ADDICTION MEDICINE, 2019, 13 (03) : 235 - 236
  • [35] Efficacy and Safety of Repeated Intermittent Treatment with Eltrombopag in Patients with Chronic Idiopathic Thrombocytopenic Purpura
    Bussel, James B.
    Psaila, Bethan
    Saleh, Mansoor N.
    Vasey, Sandra
    Mayer, Bhabita
    Stone, Nicole L.
    Arning, Michael
    BLOOD, 2008, 112 (11) : 1176 - 1177
  • [36] Treatment Options for Chronic Refractory Idiopathic Thrombocytopenic Purpura in Adults: Focus on Romiplostim and Eltrombopag
    Chouhan, Jyoti D.
    Herrington, Jon D.
    PHARMACOTHERAPY, 2010, 30 (07): : 666 - 683
  • [37] THE EFFICACY OF REVOLADE(ELTROMBOPAG) IN IDIOPATHIC AUTOIMMUNE THROMBOCYTOPENIC PURPURA(ITP)-SINGLE CENTER EXPERIENCE
    Mihaescu, R.
    Borzak, G.
    Stoian, A.
    Buzas, R.
    HAEMATOLOGICA, 2013, 98 : 742 - 742
  • [38] ORAL ELTROMBOPAG SPARES CORTICOSTEROIDS AND REDUCES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
    Bussel, J. B.
    Cheng, G.
    Saleh, M. N.
    Meddeb, B.
    Mayer, B.
    Stone, N.
    Arning, M.
    Aivado, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 125 - 125
  • [39] Treatment of immune thrombocytopenic purpura: focus on eltrombopag
    Rice, Lawrence
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 151 - 157
  • [40] IDIOPATHIC THROMBOCYTOPENIC PURPURA
    TAILLAN, B
    HASTIER, P
    FERRARI, E
    FUZIBET, JG
    GRATECOS, N
    VINTI, H
    PESCE, A
    DUJARDIN, P
    PRESSE MEDICALE, 1991, 20 (34): : 1651 - 1654
12345